Enliven Therapeutics shares owned by Longwood Capital Partners
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Longwood Capital Partners
from 13F filings
Historical chart of Longwood Capital Partners investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Longwood Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $5.2M | 265k | 19.68 |
| 2024-12-31 | $6.0M | 267k | 22.50 |
| 2024-09-30 | $7.6M | 296k | 25.54 |
| 2024-06-30 | $9.3M | 398k | 23.37 |
| 2024-03-31 | $7.0M | 396k | 17.59 |
| 2023-12-31 | $1.7M | 124k | 13.84 |
| 2023-09-30 | $1.4M | 104k | 13.66 |
| 2023-06-30 | $2.1M | 105k | 20.41 |
| 2023-03-31 | $678k | 31k | 21.90 |